Navigation Links
Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008
Date:7/29/2008

10%

GABITRIL 10% (33%) 2%

CNS 8% 21% 9%

ACTIQ (30%) 40% (19%)

Generic OTFC (6%) - (6%)

FENTORA 0% - 0%

AMRIX 100% - 100%

Pain (1%) 40% 3%

TREANDA 100% - 100%

Other (8%) 34% 26%

Oncology 295% 34% 86%

Other 4% 12% 10%

9% 22% 11%

Six Months Ended

June 30,

2008 2007

United United

States Europe Total States Europe Total

Sales:

PROVIGIL $417,411 $30,635 $448,046 $391,192 $24,267 $415,459

GABITRIL 25,438 4,332 29,770 26,862 5,387 32,249

CNS 442,849 34,967 477,816 418,054 29,654 447,708

ACTIQ 75,568 26,333 101,901 111,151 18,631 129,782

Generic OTFC 56,276 - 56,276 64,873 - 64,873

FENTORA 75,307 - 75,307 68,031 - 68,031

AMRIX 26,887 - 26,887 - - -

Pain 234,038 26,333 260,371 244,055 18,631 262,686

TREANDA 14,381 - 14,381 - - -

Other 9,568 47,642 57,210
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
10. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
11. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... According to Ross Selinger, President of Selinger ... the national office market continues to be strong, driven by ... by the third quarter’s surprising 3.9% GDP, unemployment decreasing to ... have held inflation down and the Fed is keeping interest ... remaining soft. , This solid economic news is having a ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 Nashville Fertility ... was elected treasurer for the American Society for Reproductive ... knowledge and research in reproductive medicine. In his ... seat on the executive board and will have a ... Dr. Hill has actively supported ASRM since 1984 when ...
(Date:12/24/2014)... Pipette.com announces their Holiday in ... submit their #HolidayInTheLab pictures for a chance to win ... For those struggling to think of a holiday gift ... the Lab Contest provides the ideal holiday presents. The ... send pictures of their chemistree, holiday sweaters, as well ...
(Date:12/24/2014)... Texas , Dec. 23, 2014 ... company focused on gynecologic disease, announced today that ... Schuler , Birchview Fund LLC and several Vermillion ... of unregistered shares of Vermillion,s common stock and ... stock in a private placement.  ...
Breaking Biology Technology:ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5
... 11, 2012  CBI, a division of Advanstar Communications, is ... Patient Adherence Forum, which is being held April 26 ... PA. At the event, industry experts share their strategies ... collaboration and patient engagement.  Conference highlights ...
... IndustryWeek magazine today named the Life Technologies Corporation ... one of its Top Ten Plants in North America for ... prestigious award.  IndustryWeek noted the plant,s 9% inventory ... 94% error reduction in production documentation process; $4.2 million in ...
... Danish Kroner from the VILLUM FOUNDATION paves the way for ... the world,s leading researcher in the field of quantum physics, ... to find and attract a physicist of international standing the ... grant of 38 million DKK from the VILLUM FOUNDATION. The ...
Cached Biology Technology:Complete Agenda Announced for 11th Annual Patient Adherence Forum 2Life Technologies Plant in Austin, Texas Named One of IndustryWeek's Top Ten Best Plants for 2011 2Life Technologies Plant in Austin, Texas Named One of IndustryWeek's Top Ten Best Plants for 2011 3Life Technologies Plant in Austin, Texas Named One of IndustryWeek's Top Ten Best Plants for 2011 4Niels Bohr Institute gets top researcher from Harvard 2Niels Bohr Institute gets top researcher from Harvard 3
(Date:12/10/2014)... Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ... "Biometrics Market in Japan 2014-2018" report to ... The integration of biometrics and ... and upgradation of the driver,s license is one ... Besides the aforementioned projects, biometrics is being used ...
(Date:12/5/2014)... Calif. , Dec. 4, 2014 ... has boosted investments in new testing and inspection ... also given rise to a range of innovative ... the requirements of Generation Y, which is generally ... As a result, product development strategies of test ...
(Date:12/4/2014)... Dec. 3, 2014  Crossmatch™, a leading provider ... its DigitalPersona ® Pro Enterprise software and ... deployed throughout First Bank branch locations in ... Carolina and Virginia. First Bank, a progressive ... Pines, North Carolina , selected the Crossmatch ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
... life's first cells, Irene Chen, a regional winner from North ... receive the $25,000 GE & Science Prize for Young Life ... , which is published by AAAS, the nonprofit society. , ... 11 December, during an award ceremony. She will also meet ...
... are small and spiny, they have no eyes and ... genome is remarkably similar to humans?and may hold the ... to a University of Central Florida researcher and several ... the Sea Urchin Genome Sequencing Group, which recently completed ...
... production of a gassy chemical messenger to dilate blood vessels ... cancer cells so that the immune system can recognize and ... Center. , Tests at Hopkins on mice with implanted colon ... threefold in sildenafil-treated animals, compared to mice that did not ...
Cached Biology News:American scientist's research of life's first cells 2American scientist's research of life's first cells 3American scientist's research of life's first cells 4Sea urchin genome suprisingly similar to man and may hold key to cures 2Sea urchin genome suprisingly similar to man and may hold key to cures 3'Erectile dysfunction' drugs heighten natural anti-cancer activity 2
GeneRacer is an advanced RACE (rapid amplification of cDNA ends) technique that improves the efficiency of amplifying full-length 5' and 3' cDNA ends. With the GeneRacer Kit you can:...
One-step, microplate or cuvet, colorimetric, linear detection range 0.7 mg/dL to 35 mg/dL. Procedure: 5 min....
assays for phosphatase, lipase, nucleoside triphosphatases (ATPase, GTPase etc). HTS and follow up studies for phosphatase inhibitors. Quantitation of phosphate content in protein, lipids, and DNA....
One-step, microplate or cuvet, colorimetric, detection range 0.1 mg/dL to 3 mg/dL. Procedure: 10 min....
Biology Products: